DL-CJCIPA-5
Research Blend
CJC-1295 / Ipamorelin Blend
This blend combines CJC-1295 with Drug Affinity Complex (DAC) and Ipamorelin in a single lyophilised vial. CJC-1295 is a modified GHRH analogue with covalent albumin-binding capability for extended half-life; Ipamorelin is a selective ghrelin receptor agonist. The combination is studied for potential synergistic stimulation of the GH/IGF-1 axis via complementary receptor pathways. Supplied with Certificate of Analysis and full analytical documentation. For research use only.
Select Size
Bulk pricing — buy more, save more
3+ vials
5% off
5+ vials
10% off
10+ vials
15% off
Price
£34.99
Purity
≥99%
Formula
—
Storage
-20°C
Form
Lyophilised Powder
Store at -20°C. Stable for 24 months lyophilised. For research use only. Not for human or veterinary use.
More Products
You may also like
Metabolic
Retatrutide
A novel triple agonist targeting GLP-1, GIP, and glucagon receptors, under investigation for metabolic and body composition research.
From £99.99
Metabolic
Tesamorelin
A synthetic analogue of growth hormone-releasing hormone (GHRH) with a trans-3-hexenoic acid modification that significantly extends its half-life.
From £54.99
Research Peptide
Ipamorelin
A selective growth hormone secretagogue and ghrelin receptor agonist pentapeptide that stimulates GH release without significantly elevating cortisol or ACTH.
From £44.99